Biocept, Inc. (BIOC)
Biocept has a market cap or net worth of $1.28 million. The enterprise value is $6.09 million.
The last earnings date was Wednesday, May 10, 2023, after market close.
|Earnings Date||May 10, 2023|
Biocept has 592,906 shares outstanding. The number of shares has increased by 4.57% in one year.
|Shares Change (YoY)||+4.57%|
|Shares Change (QoQ)||+3.27%|
|Owned by Insiders (%)||0.00%|
|Owned by Institutions (%)||7.99%|
|EV / Earnings||n/a|
|EV / Sales||0.54|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 2.07, with a Debt / Equity ratio of 4.77.
|Debt / Equity||4.77|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -208.30% and return on invested capital (ROIC) is -111.60%.
|Return on Equity (ROE)||-208.30%|
|Return on Assets (ROA)||-83.90%|
|Return on Capital (ROIC)||-111.60%|
|Revenue Per Employee||$227,560|
|Profits Per Employee||-$644,580|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -94.86% in the last 52 weeks. The beta is 0.92, so Biocept's price volatility has been similar to the market average.
|52-Week Price Change||-94.86%|
|50-Day Moving Average||8.27|
|200-Day Moving Average||18.20|
|Average Volume (30 Days)||132,156|
Short Selling Information
The latest short interest is 235,195, so 39.67% of the outstanding shares have been sold short.
|Short Previous Month||307,817|
|Short % of Shares Out||39.67%|
|Short % of Float||39.68%|
|Short Ratio (days to cover)||3.06|
In the last 12 months, Biocept had revenue of $11.38 million and -$32.23 million in losses. Loss per share was -$56.70.
|Loss Per Share||-$56.70|
The company has $6.77 million in cash and $11.58 million in debt, giving a net cash position of -$4.81 million or -$8.11 per share.
|Cash & Cash Equivalents||6.77M|
|Net Cash Per Share||-$8.11|
|Equity / Book Value||2.43M|
|Book Value Per Share||4.10|
In the last 12 months, operating cash flow was -$18.55 million and capital expenditures -$800,000, giving a free cash flow of -$19.35 million.
|Operating Cash Flow||-18.55M|
|Free Cash Flow||-19.35M|
|FCF Per Share||-$32.95|
Gross margin is -85.75%, with operating and profit margins of -282.48% and -283.26%.
Dividends & Yields
Biocept does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
|Price Target Difference||n/a|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
The last stock split was on May 17, 2023. It was a reverse split with a ratio of 1:30.
|Last Split Date||May 17, 2023|